Veedol's MD exit accelerated; former MD returns June 1
Arijit Basu leaves three months early; Rajendra Nath Ghosal takes over from June 1. FY26 PAT up 8.2% to ₹135.16 crore, revenue flat at ₹1,546.96 crore.
— 2 earlier stories on Veedol Corporation Ltd. →What's new
- Arijit Basu's resignation pulled forward to May 31 from Nov 3.
- Former MD Rajendra Nath Ghosal returns from June 1 through Mar 2027.
- FY26 standalone PAT up 8.2% to ₹135.16 cr; revenue flat at ₹1,546.96 cr.
Why it matters
A sudden leadership change at the top, with a former MD returning for a brief term, raises questions about strategic direction. The steady but unexciting results make the management shake-up the key focus for investors.
What we're watching
- How quickly new MD stabilises the management team.
- Any guidance on growth trajectory for FY27.
- Whether marketing head exit affects distributor relationships.
The full read
Veedol Corporation's FY26 numbers were decent but secondary to the management drama. Revenue crept up 1.3% to ₹1,546.96 crore, while PAT grew 8.2% to ₹135.16 crore. The board recommended a 1100% final dividend. However, the bigger story is the acceleration of managing director Arijit Basu's exit to May 31, 2026 — three months earlier than planned. Former MD Rajendra Nath Ghosal steps in from June 1 until March 2027, a brief tenure that suggests a stopgap arrangement. Combined with the early departure of the marketing head, the leadership pipeline looks unsettled. For a company that has delivered steady performance, the sudden reshuffle at the top injects uncertainty. Investors are left to judge whether this is a planned succession or a sign of deeper trouble.